Evidence map›Paper›PMID 34740744›Full record

ArticleThe Journal of infection2022

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine.

Estela Giménez, Juan Alberola, Ignacio Torres, Eliseo Albert, María Jesús Alcaraz, Pilar Botija, Paula Amat, María José Remigia, María José Beltrán, Celia Rodado and 3 more

Open access · bronzeAbstract readLetterComment
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Estela GiménezMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Juan AlberolaDepartment of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.
Ignacio TorresMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Eliseo AlbertMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
María Jesús AlcarazMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Pilar BotijaDepartamento de Salud Clínico-Malvarrosa, Dirección de Atención Primaria, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Paula AmatHematology Service Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
María José RemigiaHematology Service Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain.
María José BeltránDepartamento de Salud Clínico-Malvarrosa, Dirección de Enfermería, Hospital Clínico Universitario de Valencia, Valencia, Spain.
Celia RodadoDepartamento de Salud València Clínico Malvarrosa, Comisión Departamental de control de Residencias, Valencia, Spain.
Dixie HuntleyMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Beatriz OleaMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
David NavarroMicrobiology Service, Clinic University Hospital, INCLIVA Health Research Institute, Av. Blasco Ibáñez 17, Valencia 46010, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain. Electronic address: david.navarro@uv.es.
INCLIVA Health Research Institute · ESHospital Clínico Universitario de Valencia · ESUniversitat de València · ESDepartamento de Salud · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesHumansImmunityNursing HomesSARS-CoV-2COVID-19 VaccinesComirnaty® COVID-19 vaccineNursing home residentsSARS-CoV-2SARS-CoV-2-S antibodiesSARS-CoV-2-S T cells

Identifiers

PMID34740744
PMCPMC8562042
OpenAlexW3210758662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.